GC-310

N/A

Report date: 2025/09/30 20:00:06

Base Information

Drug NameGC-310
Drug Alias NameGC-310
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV5 vector
Mechanisms of ActionCopper-transporting ATPase 2 stimulants
TargetsCopper-transporting ATPase 2
Therapy Area/IndicationsGlycogen Storage Disease Type IIHepatolenticular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing GeneCradle Gene Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing GeneCradle Gene Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type IIHepatolenticular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A